Medicare Enrolled

Dr. Rajiv Anand, M.D.

Ophthalmology · Dallas, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
9600 N CENTRAL EXPY, Dallas, TX 75231
2146926941
In practice since 2005 (20 years)
NPI: 1508865254 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Anand from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Anand? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Anand

Dr. Rajiv Anand is an ophthalmology specialist in Dallas, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Anand performed 9,634 Medicare services across 3,530 unique beneficiaries.

Between the years covered by Open Payments, Dr. Anand received a total of $2,740 from 21 pharmaceutical and/or device companies across 63 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Anand is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 10% volume in TX $2,740 industry payments

Medicare Practice Summary

Medicare Utilization ↗
9,634
Medicare services
Top 10% in TX for ophthalmology
3,530
Unique beneficiaries
$142
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~482 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Retinal imaging (OCT scan) 2,347 $30 $100
Eye injection (Vabysmo/faricimab) 1,800 $29 $83
Comprehensive eye exam, established patient 1,669 $87 $200
Aflibercept eye injection (Eylea) 928 $692 $2,250
Eye injection for retinal disease 740 $84 $905
Injection, brolucizumab-dbll, 1 mg 720 $249 $750
Eye exam, established patient, focused 383 $66 $200
Comprehensive eye exam, new patient 305 $108 $275
Injection, ranibizumab, 0.1 mg 264 $183 $500
Injection, dexamethasone, intravitreal implant, 0.1 mg 227 $148 $423
Exam of retinal blood vessels using a special camera after injection of a dye 87 $107 $285
2d ultrasound scan of eye tissue and structures 66 $37 $305
Compounded drug, not otherwise classified 32 $65 $150
Removal of membrane of retina with removal of internal limiting membrane of retina 23 $916 $5,700
Repair of detached retina with drainage and removal of eye fluid between lens and retina 19 $952 $6,000
Destruction of eye fluid (vitreous) between lens and retina and all of retina using a laser 13 $831 $5,000
Complex repair of detached retina and drainage of eye fluid between lens and retina 11 $1,021 $6,500
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,740
Total received (2018-2024)
Avg $391/year across 7 years
Top 39% in TX for ophthalmology
21
Companies
63
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,240 (81.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$500 (18.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$822
2023
$428
2022
$324
2021
$171
2020
$67
2019
$648
2018
$280

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Bausch & Lomb, a division of Bausch Health US, LLC
$500
Alcon Vision LLC
$478
Alimera Sciences, Inc.
$374
Genentech USA, Inc.
$238
Novartis Pharmaceuticals Corporation
$218
Horizon Therapeutics plc
$160
Coherus Biosciences Inc.
$126
Regeneron Healthcare Solutions, Inc.
$82
Amgen Inc.
$79
Allergan, Inc.
$66
ABBVIE INC.
$66
Apellis Pharmaceuticals, Inc.
$63
Sandoz Inc.
$58
Carl Zeiss Meditec USA, Inc.
$46
Allergan Inc.
$44
Mallinckrodt Hospital Products Inc.
$34
Astellas Pharma US Inc
$32
Oculus Surgical Inc.
$24
Bausch & Lomb Americas Inc.
$23
Biogen, Inc.
$18
Retrophin, Inc.
$10
Top 3 companies account for 49.3% of total payments
Associated products mentioned in payments ›
(820) Cholbam · ACTHAR · ARTEVO 800 · BEOVU · Cimerli · Constellation · EYLEA · EYLEA AFLIBERCEPT INJECTION · ILUVIEN · Iluvien · Izervay · Lucentis · OZURDEX · PROLENSA · SUSVIMO · Syfovre · TEPEZZA · VABYSMO · Vabysmo · XIPERE · YUTIQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (82%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $28 per 100 Medicare services performed
Looking for an ophthalmology specialist in Dallas?
Compare ophthalmologists in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
285
Per 100K population
10.9
County median income
$74,149
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Anand is a mixed practice specialist, with above-average Medicare volume (top 10% in TX), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Anand experienced with retinal imaging (oct scan)?
Based on Medicare claims data, Dr. Anand performed 2,347 retinal imaging (oct scan) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Anand receive payments from pharmaceutical companies?
Yes. Dr. Anand received a total of $2,740 from 21 companies across 63 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Anand's costs compare to other ophthalmologists in Dallas?
Dr. Anand's average Medicare payment per service is $142. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Anand) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →